Direct and indirect medical costs incurred by Canadian patients with rheumatoid arthritis: A 12 year study

Journal of Rheumatology

Volumn 24, Issue 6, 1997, Pages 1051-1060

  Clarke, Ann E ^a   Zowall, Hanna ^a   Levinton, Carey ^a   Assimakopoulos, Helen ^a   Sibley, John T ^b   Haga, May ^b   Shiroky, Jeffrey ^d   Neville, Carolyn ^a   Lubeck, Deborah P ^c   Grover, Steven A ^a   Esdaile, John M ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c Technology Assessment Group   (United States)

^d DEPARTMENT OF COLORECTAL SURGERY   (United States)

Author keywords

Direct costs; Disability; Health care costs; Indirect costs; Rheumatoid arthritis

Indexed keywords

ARTICLE; CONTROLLED STUDY; DISABILITY; FEMALE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

AGED; ARTHRITIS, RHEUMATOID; CANADA; COST OF ILLNESS; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 0030923683     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Badley EM: The economic burden of musculoskeletal disorders in Canada is similar to that for cancer, and may be higher (editorial). J Rheumatol 1995;22:204-6.
2. Badley EM, Rasooly I, Webster GK: Relative importance of musculoskeletal disorders as a cause of chronic health problems, disability, and health care utilization: Findings from the 1990 Ontario Health Survey. J Rheumatol 1994;21:505-14.
3. Martin J, Meltzer H, Elliot D: The prevalence of disability among adults. OPCS Surveys of Disability in Great Britain Report 1. OPCS Social Survey Division, London: Her Majesty's Stationery Office, 1988.
4. Kosorok MR, Omenn GS, Diehr P, Koepsell TD, Patrick DL: Restricted activity days among older adults. Am J Public Health 1992;82:1263-7.
5. Schappert SM: National ambulatory medical care survey: 1989 summary. Hyattsville, MD: National Center for Health Statistics, 1992; DHHS Publication No. (PHS) 92-1771. (Vital and Health Statistics, Series 13, no. 110).
6. Yelin E, Callahan LF for the National Arthritis Data Work Group: The economic cost and social and psychological impact of musculoskeletal conditions. Arthritis Rheum 1995;38:1351-62.
7. Felts W, Yelin E: The economic impact of the rheumatic diseases in the United States. J Rheumatol 1989;16:867-84.
8. Yelin EH, Felts WR: A summary of the impact of musculoskeletal conditions in the United States. Arthritis Rheum 1990;33:750-5.
9. Yelin EH: Work disability and rheumatoid arthritis. In: Wolfe F, Pincus T, eds. Rheumatoid Arthritis: Pathogenesis, Assessment, Outcome, and Treatment. New York: Marcel Dekker, 1994:261-71.
10. Lubeck DP: The economic impact of rheumatoid arthritis. In: Wolfe F, Pincus T, eds. Rheumatoid Arthritis: Pathogenesis, Assessment, Outcome, and Treatment. New York: Marcel Dekker, 1994:247-59.
11. Allaire SH, Prashker MJ, Meenan RF: The costs of rheumatoid arthritis. Pharmacoeconomics 1994;6:513-22.
12. Meenan RF, Yelin EH, Henke CJ, Curtis DL, Epstein WV: The costs of rheumatoid arthritis: A patient-oriented study of chronic disease costs. Arthritis Rheum 1978;21:827-33.
13. Liang MH, Larson M, Thompson M, et al: Costs and outcomes in rheumatoid arthritis and osteoarthritis. Arthritis Rheum 1984;27:522-9.
14. Lubeck DP, Spitz PW, Fries JF, Wolfe F, Mitchell DM, Roth SH: A multicenter study of annual health service utilization and costs in rheumatoid arthritis. Arthritis Rheum 1986;29:488-93.
15. Wolfe F, Kleinheksel SM, Spitz PW, et al: A multicenter study of hospitalization in rheumatoid arthritis: Frequency, medical-surgical admissions, and charges. Arthritis Rheum 1986;29:614-9.
16. Wolfe F, Kleinheksel SM, Spitz PW, et al: A multicenter study of hospitalization in rheumatoid arthritis: Effect of health care system, severity, and regional difference. J Rheumatol 1986;13:277-84.
17. Yelin E, Meenan R, Nevitt M, Epstein W: Work disability in rheumatoid arthritis: Effects of disease, social and work factors. Ann Intern Med 1980;93:551-6.
18. Meenan RF, Yelin EH, Nevitt M, Epstein WV: The impact of chronic disease: A sociomedical profile of rheumatoid arthritis. Arthritis Rheum 1981;24:544-9.
19. Yelin E, Henke C, Epstein W: The work dynamics of the person with rheumatoid arthritis. Arthritis Rheum 1987;30:507-12.
20. Thompson MS: Willingness to pay and accept risks to cure chronic disease. Am J Public Health 1986;76:392-6.
21. Thompson MS, Read JL, Hutchings HC, Paterson M, Harris ED Jr: The cost effectiveness of auranofin: Results of a randomized clinical trial. J Rheumatol 1988;15:35-42.
22. Reisine ST, Goodenow C, Grady KE: The impact of rheumatoid arthritis on the homemaker. Soc Sci Med 1987;25:89-95.
23. Allaire SH, Meenan RF, Anderson JJ: The impact of rheumatoid arthritis on the household work performance of women. Arthritis Rheum 1991;34:669-78.
24. Allaire SH, DeNardo BS, Szer IS, Meenan RF, Schaller JC: The economic impacts of juvenile rheumatoid arthritis. J Rheumatol 1992;19:952-5.
25. Browne GB, Arpin K, Corey P, Fitch M, Gafni A: Individual correlates of health service utilization and the cost of poor adjustment to chronic illness. Med Care 1990;28:43-58.
26. Clarke AE, Esdaile JM, Bloch DA, Lacaille D, Danoff DS, Fries JF: A Canadian study of the total medical costs for patients with systemic lupus erythematosus and the predictors of costs. Arthritis Rheum 1993;36:1548-59.
27. Yelin EH, Henke CJ, Epstein WV: Work disability among persons with musculoskeletal conditions. Arthritis Rheum 1986;29:1322-33.
28. Jacobs J, Keyserling JA, Britton M, Morgan GJ Jr, Wilkenfeld J, Hutchings HC: The total cost of care and the use of pharmaceuticals in the management of rheumatoid arthritis: The Medi-Cal program. J Clin Epidemiol 1988;41:215-23.
29. McDuffie FC: Morbidity impact of rheumatoid arthritis on society. Am J Med 1985;(suppl 1A)78:1-5.
30. Stone CE: The lifetime costs of rheumatoid arthritis. J Rheumatol 1984;11:819-27.
31. Yelin EH, Katz PP: Labor force participation among persons with musculoskeletal conditions, 1970-1987. Arthritis Rheum 1991,34:1361-70.
32. Burkhauser RV, Butler JS, Mitchell JM, Pincus T: Effects of arthritis on wage earnings. J Gerontol 1986;41:277-81.
33. Mitchell JM, Burkhauser RV, Pincus T: The importance of age, education, and comorbidity in the substantial earnings losses of individuals with symmetric polyarthritis. Arthritis Rheum 1985;31:348-57.
34. Reynolds DL, Chambers LW, Badley EM, et al: Physical disability among Canadians reporting musculoskeletal diseases. J Rheumatol 1992;19:1020-30.
35. Weinberger M, Tierney WN, Cowper PA, Katz BP, Booher PA: Cost-effectiveness of increased telephone contact for patients with osteoarthritis: A randomized, controlled trial. Arthritis Rheum 1993;36:243-6.
36. Lorig KR, Mazonson PD, Holman HR: Evidence suggesting that health education for self-management in patients with chronic arthritis has sustained health benefits while reducing health care costs. Arthritis Rheum 1993;36:439-46.
37. Prashker MJ, Meenan RF: The total costs of drug therapy for rheumatoid arthritis. Arthritis Rheum 1995;38:318-25.
38. McInnes PM, Schuttinga J, Sanslone WR, Stark SP, Klippel JH: The economic impact of treatment of severe lupus nephritis with prednisone and intravenous cyclophosphamide. Arthritis Rheum 1994;37:1000-6.
39. Yelin EH, Henke CJ, Kramer JS, Nevitt MC, Shearn M, Epstein WV: A comparison of the treatment of rheumatoid arthritis in health maintenance organizations and fee-for-service practices. N Engl J Med 1985;312:962-7.
40. Helewa A, Bombardier C, Goldsmith CH, Menchions B, Smythe HA: Cost-effectiveness of inpatient and intensive outpatient treatment of rheumatoid arthritis: A randomized controlled trial. Arthritis Rheum 1989;32:1505-14.
41. Anderson RB, Needleman RD, Gatter RA, Andrews RP, Scarola JA: Patient outcome following inpatient vs outpatient treatment of rheumatoid arthritis. J Rheumatol 1988;15:556-60.
42. French MT, Mauskopf JA: A quality-of-life method for estimating the value of avoided morbidity. Am J Public Health 1992;82:1553-5.
43. Ropes MW, Bennett GA, Cobb S, Jacox R, Jessar RA: 1958 revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 1958;9:175-6.
44. Mitchell DM, Spitz PW, Young DY, Bloch DA, McShane DJ, Fries JF: Survival, prognosis, and causes of death in rheumatoid arthritis. Arthritis Rheum 1986;29:706-14.
45. Fries JF, Spitz P, Kraines RG, Holman HR: Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:127-34.
46. Angus DE, Auer L, Cloutier JE, Albert T: Sustainable Health Care for Canada. Queen's - University of Ottawa Economics Project, 1995.
47. Health Canada: National Health Expenditures in Canada, 1975-1994. Ottawa: Minister of Supply and Services, 1996.
48. Drummond MF, Stoddart GL, Torrance GW: Methods for the Economic Evaluation of Health Care Programmes. New York: Oxford University Press, 1987.
49. Statistics Canada: Hospital Statistics: Preliminary Annual Report. 1992-1993. Ottawa: Statistics Canada, catalogue no. 83-241, 1994.
50. Statistics Canada: Residential Care Facilities - Aged. 1992-1993. Ottawa: Statistics Canada, catalogue no. 83-237, 1994.
51. Hodgson TA, Meiners MR: Cost-of-illness methodology: A guide to current practices and procedures. Millbank Q 1982;60:429-62.
52. Statistics Canada. Selected Income Statistics. Ottawa: Statistics Canada, catalogue no. 93-331, 1993.
53. Norland JA: Profile of Canada's Seniors. Ottawa: Statistics Canada and Prentice Hall Canada, catalogue no. 96-312E, 1994.
54. Statistics Canada: Employment Earnings and Hours. Ottawa: Statistics Canada, catalogue no. 72-002, 1995.
55. Statistics Canada: Households' Unpaid Work: Measurement and Valuation. 1995. Ottawa: Statistics Canada, catalogue no. 13-603E, 1995.
56. Mayo NE, Scott S, Duval N: Rates of hip and knee arthroplasties in the province of Quebec, 1988-1992. Proceedings from the Canadian Society for Epidemiology and Biostatistics. St. John's. Newfoundland, 1995.